3-169764547-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000738610.1(ENSG00000296372):​n.162T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.263 in 645,400 control chromosomes in the GnomAD database, including 26,589 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4450 hom., cov: 33)
Exomes 𝑓: 0.28 ( 22139 hom. )

Consequence

ENSG00000296372
ENST00000738610.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.65

Publications

68 publications found
Variant links:
Genes affected
TERC (HGNC:11727): (telomerase RNA component) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, and an RNA component, encoded by this gene, that serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Mutations in this gene cause autosomal dominant dyskeratosis congenita, and may also be associated with some cases of aplastic anemia. [provided by RefSeq, Jul 2008]
TERC Gene-Disease associations (from GenCC):
  • dyskeratosis congenita, autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-169764547-T-C is Benign according to our data. Variant chr3-169764547-T-C is described in ClinVar as Benign. ClinVar VariationId is 440330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.545 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERCNR_001566.3 linkn.*63A>G downstream_gene_variant ENST00000602385.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000296372ENST00000738610.1 linkn.162T>C non_coding_transcript_exon_variant Exon 1 of 1
TERCENST00000602385.3 linkn.*63A>G downstream_gene_variant 6 NR_001566.3

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32394
AN:
152096
Hom.:
4447
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0666
Gnomad AMI
AF:
0.0965
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.176
Gnomad EAS
AF:
0.562
Gnomad SAS
AF:
0.270
Gnomad FIN
AF:
0.264
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.226
GnomAD4 exome
AF:
0.278
AC:
137234
AN:
493184
Hom.:
22139
Cov.:
0
AF XY:
0.277
AC XY:
72597
AN XY:
262432
show subpopulations
African (AFR)
AF:
0.0661
AC:
878
AN:
13290
American (AMR)
AF:
0.427
AC:
10984
AN:
25732
Ashkenazi Jewish (ASJ)
AF:
0.182
AC:
2578
AN:
14202
East Asian (EAS)
AF:
0.612
AC:
20323
AN:
33214
South Asian (SAS)
AF:
0.279
AC:
14133
AN:
50710
European-Finnish (FIN)
AF:
0.273
AC:
9143
AN:
33472
Middle Eastern (MID)
AF:
0.241
AC:
483
AN:
2004
European-Non Finnish (NFE)
AF:
0.245
AC:
71768
AN:
292876
Other (OTH)
AF:
0.251
AC:
6944
AN:
27684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
5557
11113
16670
22226
27783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
622
1244
1866
2488
3110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.213
AC:
32399
AN:
152216
Hom.:
4450
Cov.:
33
AF XY:
0.218
AC XY:
16238
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0665
AC:
2765
AN:
41560
American (AMR)
AF:
0.313
AC:
4785
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
608
AN:
3462
East Asian (EAS)
AF:
0.562
AC:
2899
AN:
5158
South Asian (SAS)
AF:
0.271
AC:
1306
AN:
4828
European-Finnish (FIN)
AF:
0.264
AC:
2799
AN:
10604
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16608
AN:
67986
Other (OTH)
AF:
0.224
AC:
474
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1268
2536
3805
5073
6341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
387
Bravo
AF:
0.214
Asia WGS
AF:
0.371
AC:
1289
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 58% of patients studied by a panel of primary immunodeficiencies. Number of patients: 55. Only high quality variants are reported.

Sep 01, 2016
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dyskeratosis congenita, autosomal dominant 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.2
DANN
Benign
0.46
PhyloP100
-2.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293607; hg19: chr3-169482335; COSMIC: COSV57754451; API